Brainsway Stock Today

BWAY Stock  USD 4.93  0.18  3.79%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 50

 
High
 
Low
About Average
Brainsway is trading at 4.93 as of the 24th of April 2024; that is 3.79 percent up since the beginning of the trading day. The stock's open price was 4.75. Brainsway has 50 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for Brainsway are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
6th of October 1999
Category
Healthcare
Classification
Health Care
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. Brainsway operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 16.64 M outstanding shares of which 74.8 K shares are currently shorted by private and institutional investors with about 0.65 trading days to cover. More on Brainsway

Moving together with Brainsway Stock

  0.86DH Definitive Healthcare Financial Report 2nd of May 2024 PairCorr
  0.61GH Guardant Health Financial Report 14th of May 2024 PairCorr
  0.65FONR FonarPairCorr

Moving against Brainsway Stock

  0.65STIM Neuronetics Financial Report 14th of May 2024 PairCorr
  0.62IRIX IRIDEX Financial Report 9th of May 2024 PairCorr
  0.53AGTI Agiliti Sell-off TrendPairCorr

Brainsway Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Brainsway's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Brainsway or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering Brainsway report their recommendations after researching Brainsway's financial statements, talking to executives and customers, or listening in on Brainsway's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Brainsway. The Brainsway consensus assessment is calculated by taking the average forecast from all of the analysts covering Brainsway.
Financial Strength
Based on the key measurements obtained from Brainsway's financial statements, Brainsway is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Brainsway is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.380.5047
Way Down
Slightly volatile
Gross Profit Margin0.860.7386
Fairly Up
Slightly volatile
Total Current Liabilities7.2 M9.8 M
Way Down
Pretty Stable
Non Current Liabilities Total7.9 M5.6 M
Way Up
Slightly volatile
Total Assets47.2 M63 M
Way Down
Slightly volatile
Total Current Assets34.2 M55.5 M
Way Down
Slightly volatile
Brainsway's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Brainsway's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Brainsway's financial leverage. It provides some insight into what part of Brainsway's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Brainsway's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Brainsway deploys its capital and how much of that capital is borrowed.
Liquidity
Brainsway cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 488 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Brainsway has a current ratio of 6.71, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Brainsway until it has trouble settling it off, either with new capital or with free cash flow. So, Brainsway's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Brainsway sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Brainsway to invest in growth at high rates of return. When we think about Brainsway's use of debt, we should always consider it together with cash and equity.

Other Cashflows From Financing Activities

(974,700)
Brainsway (BWAY) is traded on NASDAQ Exchange in USA. It is located in Bynet Building, Jerusalem, Israel, 9777518 and employs 134 people. Brainsway is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 82.83 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Brainsway's market, we take the total number of its shares issued and multiply it by Brainsway's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Brainsway conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 16.64 M outstanding shares of which 74.8 K shares are currently shorted by private and institutional investors with about 0.65 trading days to cover. Brainsway currently holds about 49.62 M in cash with 1.28 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.95.
Check Brainsway Probability Of Bankruptcy
Ownership Allocation
Brainsway holds a total of 16.64 Million outstanding shares. Brainsway shows 5.0 percent of its outstanding shares held by insiders and 24.25 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Brainsway Ownership Details

Brainsway Stock Price Odds Analysis

Based on a normal probability distribution, the odds of Brainsway jumping above the current price in 90 days from now is about 97.0%. The Brainsway probability density function shows the probability of Brainsway stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Brainsway has a beta of 0.4681 suggesting as returns on the market go up, Brainsway average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Brainsway will be expected to be much smaller as well. Additionally, brainsway has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
  Odds Below 4.93HorizonTargetOdds Above 4.93
2.72%90 days
 4.93 
97.26%
Based on a normal probability distribution, the odds of Brainsway to move above the current price in 90 days from now is about 97.0 (This Brainsway probability density function shows the probability of Brainsway Stock to fall within a particular range of prices over 90 days) .

Brainsway Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Brainsway that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Brainsway's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Brainsway's value.
InstituionRecorded OnShares
Barclays Plc2023-12-31
37.7 K
Good Life Advisors, Llc2023-12-31
35.7 K
Commonwealth Equity Services Inc2023-12-31
33 K
Jump Financial, Llc2023-12-31
32 K
Jane Street Group, Llc2023-12-31
31.9 K
Acadian Asset Management Llc2023-12-31
25.7 K
Advisor Group Holdings, Inc.2023-12-31
11.6 K
Quadrature Capital Llp2023-12-31
10.8 K
Ubs Group Ag2023-12-31
9.2 K
Aigh Capital Management, Llc2023-12-31
M
Masters Capital Management Llc2023-12-31
900 K
View Brainsway Diagnostics

Brainsway Historical Income Statement

Brainsway Income Statement is one of the three primary financial statements used for reporting Brainsway's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Brainsway revenue and expense. Brainsway Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Brainsway's Selling General Administrative is fairly stable compared to the past year. Selling And Marketing Expenses is likely to rise to about 22 M in 2024, whereas Interest Expense is likely to drop slightly above 45.6 K in 2024. View More Fundamentals

Brainsway Stock Against Markets

Picking the right benchmark for Brainsway stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Brainsway stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Brainsway is critical whether you are bullish or bearish towards Brainsway at a given time. Please also check how Brainsway's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Brainsway without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Aroon Oscillator Now

   

Aroon Oscillator

Analyze current equity momentum using Aroon Oscillator and other momentum ratios
All  Next Launch Module

Brainsway Corporate Management

Elected by the shareholders, the Brainsway's board of directors comprises two types of representatives: Brainsway inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Brainsway. The board's role is to monitor Brainsway's management team and ensure that shareholders' interests are well served. Brainsway's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Brainsway's outside directors are responsible for providing unbiased perspectives on the board's policies.
Menachem EsqGeneral VPProfile
Christopher JakoPres CEOProfile
Ido MaromChief OfficerProfile
Avner HagaiFounder ViceChairmanProfile
Christopher BoyerVice MarketingProfile
Hadar LevyChief OfficerProfile
Yiftach RothChief ScientistProfile

How to buy Brainsway Stock?

Before investing in Brainsway, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Brainsway. To buy Brainsway stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Brainsway. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Brainsway stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Brainsway stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Brainsway stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Brainsway, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Brainsway Stock please use our How to Invest in Brainsway guide.

Already Invested in Brainsway?

The danger of trading Brainsway is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Brainsway is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Brainsway. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Brainsway is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Brainsway offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainsway's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainsway Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainsway Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brainsway. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Brainsway Stock please use our How to Invest in Brainsway guide.
Note that the Brainsway information on this page should be used as a complementary analysis to other Brainsway's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Brainsway Stock analysis

When running Brainsway's price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Fundamental Analysis
View fundamental data based on most recent published financial statements
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Is Brainsway's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brainsway. If investors know Brainsway will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brainsway listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.26)
Revenue Per Share
1.918
Quarterly Revenue Growth
0.497
Return On Assets
(0.05)
Return On Equity
(0.1)
The market value of Brainsway is measured differently than its book value, which is the value of Brainsway that is recorded on the company's balance sheet. Investors also form their own opinion of Brainsway's value that differs from its market value or its book value, called intrinsic value, which is Brainsway's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brainsway's market value can be influenced by many factors that don't directly affect Brainsway's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brainsway's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brainsway is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainsway's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.